FDA Advises Manufacture of New COVID-Variant Vaccines
FDA Advises Manufacture of New COVID-Variant Vaccines
The U.S. Food and Drug Administration’s Covid strain selection for the next round of shots puts Pfizer, Moderna, and Novavax on track to deliver new jabs in time for the fall — a decisive win for the vaccine makers as they gear up to compete against one another. The vaccine will target XBB 1.5, which has been the dominant COVID subvariant in the […]